Mutations at BCL11B Exon 4 Associated with T Cell Acute Lymphoblastic Leukemia Are Facilitated by AID and Formation of Non-B DNA Conformations

Mol Cell Biol. 2024;44(12):590-606. doi: 10.1080/10985549.2024.2419661. Epub 2024 Nov 7.

Abstract

One of the primary reasons behind the pathogenesis of T cell acute lymphoblastic leukemia (T-ALL) is the deregulation of the transcription factor BCL11B. The exon 4 of BCL11B harbors several driver mutations, which abolishes its DNA-binding ability. The high frequency of C > T or G > A conversion in close vicinity of AID (Activation-induced cytidine deaminase)-hotspot motifs in the deregulated gene prompted us to investigate the role of AID in BCL11B mutagenesis. Our results reveal that AID is expressed in T-ALL patient-derived cells, binds to BCL11B fragile region (FR) in exon 4 of T cells in vivo, and generates a signature mutation pattern in this region. The mutation frequency in BCL11B FR could be modulated upon overexpression of the AID gene in the knockout background, further suggesting the involvement of AID in BCL11B mutagenesis. Importantly, various lines of experimentation reveal that BCL11B FR could fold into parallel G-quadruplex, triplex, and hairpin structures, which could act as a replication/transcription block, causing mutagenesis. Thus, our results suggest that AID binds to BCL11B exon 4 due to non-B DNA formation, causing U:G mismatches or replication blocks, which, when repaired erroneously, generates deleterious mutations, resulting in loss of functionality of BCL11B, and thus becomes the cause of T-ALL.

Keywords: AID; G4 DNA; Genomic fragility; chromosomal translocation; cruciform DNA; cytidine deaminase; double-strand break repair; genomic lesions; lymphoid cancer; non-B DNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Cytidine Deaminase* / genetics
  • Cytidine Deaminase* / metabolism
  • DNA / genetics
  • DNA / metabolism
  • Exons* / genetics
  • G-Quadruplexes
  • Humans
  • Mutagenesis
  • Mutation* / genetics
  • Nucleic Acid Conformation
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / genetics
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / metabolism
  • Repressor Proteins* / genetics
  • Repressor Proteins* / metabolism
  • Tumor Suppressor Proteins* / genetics
  • Tumor Suppressor Proteins* / metabolism

Substances

  • BCL11B protein, human
  • Repressor Proteins
  • Cytidine Deaminase
  • Tumor Suppressor Proteins
  • AICDA (activation-induced cytidine deaminase)
  • DNA

Grants and funding

This work was supported by grants from DAE, India (Grant No. 21/01/2016-BRNS/35074) to SCR and COE (BT/PR13458/COE/34/33/2015) to SCR and BC and financial assistance from IISc-DBT partnership program (BT/PR27952-INF/22/212/2018) to SCR. SCR is a JC Bose National Fellow (JCB/2023/000041). UR, AS, and SD are supported by Senior Research Fellowship from IISc.